Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer
Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
In this study we aim to more precisely define the clinical utility of PSMA imaging across a
range of clinical indications in men with prostate cancer. To accomplish this, we will make
the 18F-DCFPyL PET/CT scan available to urologists, medical oncologists, and radiation
oncologists at Johns Hopkins and survey physicians as to the indication for ordering the
PET/CT and if a change in management occurred as the result of new information gained from
the scan. We believe these data will prove critical for planning future studies aimed at
evaluating the efficacy of this test for improving patient outcomes.
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins